Prevalence of ESR1 Mutation in Chinese ER-Positive Breast Cancer

BACKGROUND: ESR1 mutation and its possible relation to endocrine therapy resistance in ER-positive breast cancers have been studied with respect to genetic sequencing data from Western patients but rarely from Chinese patients. This study aimed to investigate the prevalence of ESR1 mutation in Chine...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Onco Targets Ther
Hlavní autoři: Zhu, Wenzhen, Ren, Chongyang, Wang, Yulei, Wen, Lingzhu, Zhang, Guochun, Liao, Ning
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6982432/
https://ncbi.nlm.nih.gov/pubmed/32021303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S233662
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky